Cellular and Molecular Study in Immunopharmacology

Dear Colleagues,

Immunopharmacology is a combination of immunology and pharmacology that investigates the cellular and molecular responses of preventative and therapeutic drugs. This discipline is fast evolving and has become a required topic in life science graduate studies. Significant progress has been made in understanding numerous aspects of immunopharmacological targets, both at the cellular and molecular levels. Nonetheless, more has to be learned about immune cell-to-non-immune cell contacts, mediator expression, and their roles in physiology, disease, and diagnosis. Many new therapies have become accessible as a result of significant advances in drug research in recent years. These include vaccines, adjuvants, nucleic acid-based therapies, cell-based therapies, natural chemical substances, small molecules, and various forms of engineered antibodies or antibody fragments. Indeed, to understand the cellular and molecular mechanisms in immunopharmacology, more studies into the above-mentioned drugs that modulate immune responses are needed in both preclinical and clinical settings. The aim of this special issue is to attract research studies that have explored novel methods to understand the cellular and molecular mechanisms involved in preventive and therapeutic substances in the field of immunopharmacology. 

I invite the researchers to submit original research articles, brief reports, reviews, mini-reviews, and opinions that encompass the following recent advancements:

• Immunomodulators that have the ability to specifically enhance or suppress immune responses. 
• Vaccines and vaccine adjuvants that augment the antigen-specific immune response, resulting in increased protection. 
• Infections (caused by bacteria, fungi, viruses, or other pathogens) that induce immunological changes. 
• Novel findings in autoimmunity, and potential therapeutic approaches.

Dr. Srinivasa Reddy Bonam
Guest Editor

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2600 USD. Submitted manuscripts should be well formatted in good English.